相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)
Jacobien M. Kieffer et al.
QUALITY OF LIFE RESEARCH (2017)
The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems
Tsung-Ping Su et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Investigational sigma-1 receptor antagonists for the treatment of pain
Jose Miguel Vela et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)
Deirdre R. Pachman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Reliability and accuracy of quantitative sensory testing for oxaliplatin-induced neurotoxicity
R. Velasco et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
P. Alberti et al.
ANNALS OF ONCOLOGY (2014)
Oxaliplatin-Induced Neuropathy in Colorectal Cancer: Many Questions With Few Answers
Ahmed Hussein Zedan et al.
CLINICAL COLORECTAL CANCER (2014)
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients
Roser Velasco et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice
Francisco R. Nieto et al.
MOLECULAR PAIN (2014)
Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain
Marco Sisignano et al.
NATURE REVIEWS NEUROLOGY (2014)
Oxaliplatin Neurotoxicity
Roser Velasco et al.
CURRENT COLORECTAL CANCER REPORTS (2014)
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
G. Cavaletti et al.
ANNALS OF ONCOLOGY (2013)
Safety, tolerability and pharmacokinetics of single and multiple doses of a novel sigma-1 receptor antagonist in three randomized phase I studies
Montserrat Abadias et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Clinical pattern and associations of oxaliplatin acute neurotoxicity
Andreas A. Argyriou et al.
CANCER (2013)
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy A Randomized Clinical Trial
Ellen M. Lavoie Smith et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Chemotherapy-Induced Neuropathy and Its Association With Quality of Life Among 2-to 11-Year Colorectal Cancer Survivors: Results From the Population-Based PROFILES Registry
Floortje Mols et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization
L. Romero et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
Andreas A. Argyriou et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Role of Sigma-1 Receptors in Paclitaxel-Induced Neuropathic Pain in Mice
Francisco Rafael Nieto et al.
JOURNAL OF PAIN (2012)
Longitudinal assessment of oxaliplatin-induced neuropathy
A. Z. Burakgazi et al.
NEUROLOGY (2011)
Dose Effects of Oxaliplatin on Persistent and Transient Na+ Conductances and the Development of Neurotoxicity
Susanna B. Park et al.
PLOS ONE (2011)
Thermoreception and nociception of the skin: a classic paper of Bessou and Perl and analyses of thermal sensitivity during a student laboratory exercise
Johann P. Kuhtz-Buschbeck et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2010)
Thermoreceptors and thermosensitive afferents
Raf J. Schepers et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy
Susanna B. Park et al.
BRAIN (2009)
Acute Abnormalities of Sensory Nerve Function Associated With Oxaliplatin-Induced Neurotoxicity
Susanna B. Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study
N. Attal et al.
PAIN (2009)
Tools for Assessing Neuropathic Pain
Giorgio Cruccu et al.
PLOS MEDICINE (2009)
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale
Guido Cavaletti et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2007)
Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy
A. A. Argyriou et al.
NEUROLOGY (2006)
Quantitative sensory testing: a comprehensive protocol for clinical trials
R Rolke et al.
EUROPEAN JOURNAL OF PAIN (2006)
Innocuous cooling can produce nociceptive sensations that are inhibited during dynamic mechanical contact
BG Green et al.
EXPERIMENTAL BRAIN RESEARCH (2003)